For those that lived through the devastation and horror of the HIV/AIDS epidemic of the early 1980s, effective treatment, let alone a cure for Human Immunodeficiency Virus (HIV), seemed unimaginable.
Some three decades later, a host of Maryland life science companies and research organizations are getting closer to making what was once unthinkable, real.
So little was known about this devastating immune disorder in the early phases of the HIV/AIDS epidemic.
